The undiagnosed HIV epidemic in France and its implications for HIV screening strategies

AIDS

Volumn 28, Issue 12, 2014, Pages 1797-1804

  Supervie, Virginie ^a,b   Ndawinz, Jacques D A ^a,b   Lodi, Sara ^c,d   Costagliola, Dominique ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

distribution of time since HIV infection; hidden epidemic; HIV; mathematical modeling; screening strategy; undiagnosed infection

Indexed keywords

CD4 ANTIGEN; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVAL; CONTROLLED STUDY; EPIDEMIC; FEMALE; FRANCE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; PRIORITY JOURNAL; SCREENING; ADOLESCENT; HIV INFECTIONS; MASS SCREENING; MIDDLE AGED; PROCEDURES; THEORETICAL MODEL; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; EPIDEMICS; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; PARIS; TIME FACTORS; YOUNG ADULT;

EID: 84904200117     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000270     Document Type: Article

References (34)

1. UNAIDS. Report on the global AIDS epidemic. http//www. unaids.org/en/media/unaids/contentassets/documents/epide miology/2013/gr2013/ UNAIDS-Global-Report-2013-en.pdf (Accessed 27 March 2014).
2. Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS 2012 26893-896.
3. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006 201447-1450.
4. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008 198687-693.
5. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005 39446-453.
6. Writing Comittee for the CASCADE collaboration. Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1, seroconverters. Arch Intern Med 2011 1711560-1569.
7. Montlahuc C, Guiguet M, Abgrall S, Daneluzzi V, de Salvaldor F, Launay O, et al. Impact of late presentation on the risk of death among HIV-infected people in France (2003-2009). J Acquir Immune Defic Syndr 2013 64197-203.
8. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, Harris R, et al. Timing of initiation of antiretroviral therapy in AIDSfree HIV-1-infected patients a collaborative analysis of 18 HIV cohort studies. Lancet 2009 3731352-1363.
9. Mounier-Jack S, Nielsen S, Coker RJ. HIV testing strategies across European countries. HIV Med 2008 9 (Suppl 2)13-19.
10. Centers for disease Control, Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006 551-17.
11. Haute Autorité de Santé. [HIV infection screening in France-Screening Strategies-executive summary.] October 2009. Available from http//www.has-sante.fr/portail/upload/docs/application/pdf/2010-02/ hiv-infection-screening-in-france-screening
12. Health Protection Agency. Time to test for HIV expanding HIV testing in healthcare and community services in England. 2011. http//www.hpa.org.uk/webc/ HPAwebFile/HPAweb-C/1316424799217 (Accessed 27 March 2014).
13. Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr 2010 53619-624.
14. Working group on Estimation of HIV prevalence in Europe. HIV in hiding methods and data requirements for the estimation of the number of people living with undiagnosed HIV. AIDS 2011 251017-1023.
15. Birrell PJ, Gill ON, Delpech VC, Brown AE, Desai S, Chadborn TR, et al. HIV incidence in men who have sex with men in England and Wales 2001-10 a nationwide population study. Lancet Infect Dis 2013 13313-318.
16. Brookmeyer R. Measuring the HIV/AIDS epidemic approaches and challenges. Epidemiol Rev 2010 3226-37.
17. Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiebaut R, et al. Time from human immunodeficiency virus seroconversion to reaching CD4R cell count thresholds
18. National Institute ,Statistics and Economic Studies (INSEE). http//www.insee.fr/en (Accessed 27 March 2014).
19. Bajos N, Bozon M, Beltzer N. Enquête sur la sexualité en France Pratiques, genre et santé. Paris Editions La Découverte 2008.
20. Costes JM, Vaissade L, Colasante E, Palle C, Legleye S, Janssen E, et al. Prévalence de l'usage problématique de drogues en France-estimations 2006. Saint-Denis Observatoire Français des Drogues et des Toxicomanies 2009.
21. Yeni P. Report on the medical management of persons lnfected with HIV, under the direction of Prof. Patrick Yeni [in French]. Available from http//www.sante.gouv.fr/IMG/pdf/Rapport-2010-sur-la-prise-en-charge-medicale- des-personnes-infec tees-par-le-VIH-sous-la-direction-du-Pr-Patrick-Yeni.pdf (Accessed 27 March 2014).
22. Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection a consensus definition. HIV Med 2011 1261-64.
23. Cazein F, Pinget R, Lot F, Pillonel J, Le Strat Y, Sommen C, et al. New HIV and AIDS diagnoses-France, 2003-2011. Bull Epidémiol Hebdomadaire 2013 28-29333-340.
24. Ministère de la santé et des Sports. National HIV and STIs plan for 2010-2014 [in French]. November 2010. Available from http//www.sante.gouv.fr/IMG/pdf/plan-national-lutte-contre-le-VIH-SIDA-et-les- IST-2010-2014.pdf (Accessed 27 March 2014).
25. Cazein F, Barin F, Le Strat Y, Pillonel J, Le Vu S, Lot F, et al. Prevalence and characteristics of individuals with undiagnosed HIV infection in France evidence from a survey on hepatitis B and C seroprevalence. J Acquir Immune Defic Syndr 2012 60e116-e118.
26. Lodi S, Phillips A, Touloumi G, Pantazis N, Bucher HC, Babiker A, et al. CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era. AIDS 2010 242697-2704.
27. Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, et al. Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa. PLoS One 2012 7e32369.
28. d'Almeida KW, Kierzek G, de Truchis P, Le Vu S, Pateron D, Renaud B, et al. Modest public health impact of nontargeted human immunodeficiency virus screening in 29 emergency departments. Arch Intern Med 2012 17212-20.
29. Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D, et al. Routine HIV screening in France clinical impact and cost-effectiveness. PLoS One 2010 5e13132.
30. Le Vu S, Le Strat Y, Barin F, Pillonel J, Cazein F, Bousquet V, et al. Population-based HIV-1 incidence in France, 2003-2008 a modelling analysis. Lancet Infect Dis 2010 10682-687.
31. Champenois K, Le Gall JM, Jacquemin C, Jean S, Martin C, Rios L, et al. ANRS-COM'TEST description of a community-based HIV testing intervention in nonmedical settings for men who have sex with men. BMJ Open 2012 2e000693.
32. Rouzioux C, Le Talec JY, Kreplak G, Tessier P, Sebbah G, Tellier G, et al. Frequent HIV testing in a community setting improves detection of acute and recent infections, among MSM in Paris, France (Checkpoint study). International AIDS Conference. Rome, Italy 2011.
33. Alvarez-Del Arco D, Monge S, Azcoaga A, Rio I, Hernando V, Gonzalez C, et al. HIV testing and counselling for migrant populations living in high-income countries a systematic review. Eur J Public Health 2013 231039-1045.
34. Casalino E, Bernot B, Bouchaud O, Alloui C, Choquet C, Bouvet E, et al. Twelve months of routine HIV screening in 6 emergency departments in the Paris area results from the ANRS URDEP study. PloS One 2012 7e46437.